Biomm
Biomm S.A. operates as a biotechnology company in Brazil. The company offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANE...
Biomm Logo
About Biomm
Biomm SA is a biotechnology company. The Company produces human and swine insulins using recombinant DNA techniques. Biomm serves customers in Brazil.
Address
705 – Lagoa dos Ingleses, Avenida Regent Alphaville
Nova Lima, 34018-000
Brazil
Year founded
2001
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
